Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
Market Definition The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors).
Any currency conversions used in the production of this report have been calculated at constant 2011 annual average exchange rates.
TABLE OF CONTENTSIntroduction 8What is this report about? 8Who is the target reader? 8How to use this report 8Definitions 8Scandinavia Pharmaceuticals Industry Outlook 9Pharmaceuticals in Denmark 12Market Overview 12Market Data 13Market Segmentation 14Market outlook 16Five forces analysis 17Macroeconomic indicators 25Pharmaceuticals in Norway 27Market Overview 27Market Data 28Market Segmentation 29Market outlook 31Five forces analysis 32Macroeconomic indicators 40Pharmaceuticals in Sweden 42Market Overview 42Market Data 43Market Segmentation 44Market outlook 46Five forces analysis 47Macroeconomic indicators 55Company Profiles 57Leading companies 57Appendix 89Methodology 89
LIST OF TABLES
Table 1: Scandinavia pharmaceuticals industry, revenue ($bn), 2007-16 9
Table 2: Scandinavia pharmaceuticals industry, revenue ($bn), 2007-16 10
Table 3: Scandinavia pharmaceuticals industry forecast, revenue ($bn), 2011-16 11
Table 4: Denmark pharmaceuticals market value: $ billion, 2007–11 13
Copyright©2012 PR Newswire.
All rights reserved
Related medicine technology :
1. RoundTable Healthcare Partners and Argon Medical Devices to Acquire Angiotech Pharmaceuticals Interventional Products Business
2. First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals Lead Therapeutic Candidate for Treatment of Migraine, ALD403
3. Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash
4. Tech Coast Angels Contributes More Than $3 Million to $16 Million Savara Pharmaceuticals Series B
5. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
6. Star Scientific and Rock Creek Pharmaceuticals Report on the Beneficial Nutritional Effects of Anatabine in an Animal Model of Ulcerative Colitis
7. Inovio Pharmaceuticals Reports 2012 Fourth Quarter and Year End Financial Results
8. Cadence Pharmaceuticals Appoints Stephen L. Newman, M.D., to its Board of Directors
9. Isis Pharmaceuticals to Host Investor Event to Discuss ISIS-SMN Rx Data Presented at 2013 AAN Annual Meeting
10. Sagent Pharmaceuticals Selects ProspectoRx and Clinical Pharmacology
11. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Spectrum Pharmaceuticals, Inc.